These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4029248)

  • 1. Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.
    Abernethy DR; Todd EL
    Eur J Clin Pharmacol; 1985; 28(4):425-8. PubMed ID: 4029248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired elimination of caffeine by oral contraceptive steroids.
    Patwardhan RV; Desmond PV; Johnson RF; Schenker S
    J Lab Clin Med; 1980 Apr; 95(4):603-8. PubMed ID: 7359014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Divoll M; Arendt R; Ochs HR; Shader RI
    N Engl J Med; 1982 Apr; 306(13):791-2. PubMed ID: 7062953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of antipyrine metabolism by low-dose oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ
    Clin Pharmacol Ther; 1981 Jan; 29(1):106-10. PubMed ID: 7460468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic oral contraceptive steroids on theophylline disposition.
    Tornatore KM; Kanarkowski R; McCarthy TL; Gardner MJ; Yurchak AM; Jusko WJ
    Eur J Clin Pharmacol; 1982; 23(2):129-34. PubMed ID: 7140802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
    Meffin PJ; Wing LM; Sallustio BC; Brooks PM
    Br J Clin Pharmacol; 1984 Jun; 17(6):655-64. PubMed ID: 6743464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
    Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
    Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metamizol-caffeine elimination in females with increased serum aminotransferase activities treated with steroidal oral contraceptives].
    Bergmann M; Splinter FC; Henschel L; Balogh A; Hoffmann A; Klinger G
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(5):261-7. PubMed ID: 3150832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
    Gardner MJ; Tornatore KM; Jusko WJ; Kanarkowski R
    Br J Clin Pharmacol; 1983 Sep; 16(3):271-80. PubMed ID: 6626419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids.
    Rietveld EC; Broekman MM; Houben JJ; Eskes TK; van Rossum JM
    Eur J Clin Pharmacol; 1984; 26(3):371-3. PubMed ID: 6734698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
    Granfors MT; Backman JT; Laitila J; Neuvonen PJ
    Clin Pharmacol Ther; 2005 Oct; 78(4):400-11. PubMed ID: 16198659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased metabolic clearance of acetaminophen with oral contraceptive use.
    Abernethy DR; Divoll M; Ochs HR; Ameer B; Greenblatt DJ
    Obstet Gynecol; 1982 Sep; 60(3):338-41. PubMed ID: 6897933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.
    Mönig H; Baese C; Heidemann HT; Ohnhaus EE; Schulte HM
    Br J Clin Pharmacol; 1990 Jul; 30(1):115-8. PubMed ID: 2390422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
    Chambers DM; Jefferson GC; Chambers M; Loudon NB
    Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of oral contraceptives on drug therapy.
    Teichmann AT
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2208-13. PubMed ID: 2256528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of oral contraceptives and cardiovascular disease.
    Chasan-Taber L; Stampfer MJ
    Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.